Developer docs
API playgroundTry for free, no card

Search company profiles

ELDON

Full company profile

uuid000odfn

Namestring
ELDON
Legal namestring
Eldon Biologicals A/S
Websiteurl
eldoncard.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Eldon Biologicals A/S is a privately held Danish medical device manufacturer headquartered in Gentofte, north of Copenhagen. The company produces the EldonCard, a dry-format blood typing card using dried monoclonal antibody formulations on special plastic to determine ABO and Rhesus D blood groups at the point of care. The product requires only 5 µl of whole blood, delivers results in approximately two minutes, has a 24-month shelf life at 5–37 °C without refrigeration, and is validated to 99.9% concordance with standard laboratory methods across multi-country studies. The EldonCard is ISO 13485 certified, CE marked in the EU, cleared by the US FDA, and listed on the WHO Essential Diagnostics List and the WHO Compendium of Innovative Health Technologies for Low-Resource Settings.

The company's product portfolio centers on the core EldonCard and includes a dedicated Rhesus card for maternal health settings, a single-use safety lancet, and a home blood type testing kit sold through Amazon. Eldon Biologicals earns revenue primarily through one-time sales of cards and accessories to healthcare providers, hospitals, military medical units, NGOs, and clinical laboratories, channeled through a global authorized distributor network spanning more than 40 countries across Europe, Africa, Asia, North America, South America, and Oceania; consumer home kits are sold directly through the Amazon marketplace. Commercial pricing is not publicly disclosed and is negotiated through distributors.

Eldon Biologicals maintains a small operational footprint (reported headcount of 1–10) and pursues impact-oriented partnerships with institutions including UNICEF, the Leiden University Medical Centre, Sanquin, the Kenya Obstetrical and Gynecological Society, the AFRICARhE Consortium, WIRhE, and tactical-medicine programs in Ukraine, focused on Rhesus disease prevention, postpartum hemorrhage management, and field blood typing.

Short descriptiontext

Eldon Biologicals A/S is a Danish medical device manufacturer that produces the EldonCard, a dry-format point-of-care blood typing card for ABO and Rhesus D determination, serving hospitals, militaries, NGOs, and consumers via a global distributor network and Amazon.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGentofte, Denmark
HQ citystring
Gentofte
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blood grouping cards, point-of-care diagnostics, ABO Rhesus typing, dry format immunohematology, home blood type testing
Industry2 codes
PRIMARYHLAHAAAH
Blood Bank, Transfusion Medicine & Immunohematology
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAG
Transfusion Medicine & Immunohematology (Blood Bank)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In-Vitro Diagnostic Medical Devices
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeOne Time License
Description

Sale of EldonCards and related blood typing products to healthcare providers, hospitals, military medical units, and clinical laboratories globally through distributor network.

eldoncard.com
2Consumer/Home Testing Kits
TypeOne Time License
Description

Direct-to-consumer sales of home blood type testing kits through Amazon marketplace for individual users wanting to know their blood type.

eldoncard.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Eldon Biologicals A/S manufactures and sells the EldonCard product line, a dry-format point-of-care blood typing system for ABO and Rhesus D blood grouping. The cards use dried monoclonal antibody formulations on special plastic substrates and deliver blood type results in approximately 2 minutes from as little as 5 µl of whole blood, without refrigeration or laboratory infrastructure. The portfolio serves healthcare providers, military medical units, maternal health programs, NGOs, and individual consumers through a global distributor network and Amazon home-test kits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 99.9% concordance with standard blood typing procedures in multi-country laboratory validation studies
+3 more records
Product overview1 text field

Eldon Biologicals A/S manufactures and sells the EldonCard product line—a dry format blood typing system for ABO and Rhesus (D) blood grouping. The core EldonCard product consists of plastic cards with dried monoclonal antibody formulations that provide rapid, point-of-care blood type determination without requiring refrigeration or laboratory equipment. The portfolio includes the standard EldonCard, the Home Kit for personal blood type testing, the specialized Rhesus Card for maternal health settings, and single-use safety lancets. The system is designed for both professional medical use and home testing, delivering results in 2 minutes from minimal blood samples.

Product and service4 records
1EldonCard
CategoryPoint-of-care blood typing device
Description

Dry-format plastic card with dried monoclonal antibody reagents used for point-of-care ABO and Rhesus D blood grouping. Provides blood type results in 2 minutes from 5 µl of whole blood without refrigeration or laboratory equipment; shelf life 24 months at 5–37 °C; ISO 13485, CE marked, US FDA cleared.

2Eldon Blood Type Test (Home Kit)
CategoryHome diagnostic test kit
Description

Consumer home blood typing kit containing an EldonCard with four circles of dried antibody reagents plus an instructions guide for interpreting agglutination patterns. Sold directly to individual consumers via Amazon for personal blood type determination.

3Eldon Safety Lancet
CategoryBlood collection accessory
Description

Disposable single-use safety lancet with a post-use activation safety mechanism that prevents accidental piercing, used to draw the small whole-blood sample required for the EldonCard test.

4EldonCard Rhesus Card
CategoryMaternal health screening device
Description

Specialized EldonCard variant designed for Rhesus status screening of pregnant women in birth centres, birth clinics, and abortion clinics to support Rhesus disease prophylaxis and maternal health programs.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
1PULSE - Tactical Medicine for Ukraine
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-19
Description

Partnership for pre-hospital blood transfusion training for Ukrainian Armed Forces. EldonCards used for rapid blood type determination in combat medicine scenarios, enabling timely life-saving transfusions.

eldoncard.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-30
Description

Partnership to provide UNICEF with EldonCards as a tool strengthening maternal and child health programs across UNICEF's operations in over 190 countries.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-10
Description

Ukrainian blood donor organization partnership for Walking Blood Bank initiative. Donor registration and free blood type testing using EldonCards at outreach activities.

4AFRICARhE Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-01
Description

Three-country initiative in Ethiopia, Malawi, and Tanzania involving LUMC, Sanquin, Haramaya University, Hiwot Fana Specialized University Hospital, Queen Elizabeth Central Hospital, and Kilimanjaro Christian Medical Centre. Blood type testing of 10,000 pregnant women per country.

eldoncard.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-05-01
Description

Presentation of EldonCard at Caritas Africa General Assembly in Rome. Discussions on Rhesus disease prevention and blood donor mobilization across African healthcare systems.

6Kenya Obstetrical and Gynecological Society (KOGS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded pilot project implementing Rhesus disease prevention through blood type testing of pregnant women using EldonCards. Part of the broader End PPH Project targeting postpartum hemorrhage.

eldoncard.com
7Walking Blood Bank Ukraine
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with DonorUA and Yashchenko Foundation to develop and expand Walking Blood Bank in Ukraine, addressing shortage of donor blood through rapid blood type testing and donor registration.

eldoncard.com
8End PPH Project
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership including KOGS, Midwifes Association of Kenya, University of Nairobi to tackle postpartum hemorrhage - a leading cause of maternal mortality in Kenya (25-45% of maternal deaths). EldonCards support blood donor mobilization.

eldoncard.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dutch blood services provider collaborating on African Rhesus disease prevention projects. Discussed cooperation focusing on field testing and scaling up Rhesus disease prevention in Ethiopia, Malawi, and Tanzania.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading global initiative to eradicate Hemolytic Disease of the Fetus and Newborn (HDFN/Rhesus disease). Developed two-phase study to tackle the disease in sub-Saharan Africa.

11WIRhE (Worldwide Initiative for Rh Disease Eradication)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global partnership dedicated to Rhesus disease eradication. Eldon Biologicals supports efforts with point-of-care testing technology for screening and prevention programs.

eldoncard.com
Strategic tierMinorTypeOthers
Description

Cooperation with seven different protected workplaces providing genuine employment opportunities for people living with disabilities in production and assembly.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Bio-Rad's DiaMed line supplies blood typing reagents, gel cards, and instrumentation used in transfusion medicine. As a broad diagnostics incumbent, Bio-Rad overlaps with Eldon in the same clinical workflow but offers a much wider product portfolio.

TypeBroad incumbent
Description

Siemens Healthineers offers blood typing and immunohematology solutions as part of its central lab diagnostics franchise. It targets the same clinical use case as EldonCard but via high-throughput analyzers in established lab environments.

TypeBroad incumbent
Description

Grifols produces blood typing reagents and is a major player in transfusion diagnostics as part of its broader plasma and diagnostics business. It competes with Eldon in the same clinical indication but with a portfolio-focused, integrated blood bank offering.

TypeDirect peer
Description

Immucor, now part of Werfen, is a global leader in transfusion and immunohematology diagnostics, offering manual and automated blood typing reagents and instruments. It is the most direct large-scale competitor to EldonCard in hospital blood bank workflows.

TypeDirect peer
Description

Quotient develops the MosaiQ blood transfusion diagnostics platform for donor typing and patient screening. It competes with EldonCard at the immunohematology testing step in blood banks, though via a higher-throughput centralized instrument rather than a point-of-care card.

TypeEmerging player
Description

HemoCue provides point-of-care blood diagnostics (notably hemoglobin and glucose) for field and primary care settings. While not a direct blood typing competitor, it is comparable as a small-format, no-refrigeration POC diagnostics brand addressing similar low-resource and emerging-market customers.

TypeEmerging player
Description

Biomedomics develops point-of-care blood typing tests targeted at low-resource settings, including a lateral flow typing device. It is the closest emerging direct competitor to EldonCard in field/decentralized blood typing use cases.

TypeDirect peer
Description

Silver Lake Research markets the Typenex home blood typing kit, a direct analogue of Eldon's Amazon home kit. It is the closest pure-play comparable in the consumer blood typing segment where Eldon also competes.

9Abbott Diagnostics
TypeBroad incumbent
Description

Abbott is a global diagnostics incumbent offering blood typing and transfusion-related assays as part of its broader core lab and POC portfolio. It competes with Eldon for hospital transfusion medicine budgets, though ABO/Rhesus is a small slice of its portfolio.

TypeBroad incumbent
Description

QuidelOrtho manufactures immunohematology reagents and the ORTHO VISION analyzer for blood banks. It addresses the same clinical need as EldonCard (ABO/Rhesus determination) but is geared toward centralized hospital labs rather than field point-of-care use.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ELDON

In-Vitro Diagnostic Medical Deviceseldoncard.com

Eldon Biologicals A/S is a Danish medical device manufacturer that produces the EldonCard, a dry-format point-of-care blood typing card for ABO and Rhesus D determination, serving hospitals, militaries, NGOs, and consumers via a global distributor network and Amazon.

What ELDON does

Eldon Biologicals A/S is a privately held Danish medical device manufacturer headquartered in Gentofte, north of Copenhagen. The company produces the EldonCard, a dry-format blood typing card using dried monoclonal antibody formulations on special plastic to determine ABO and Rhesus D blood groups at the point of care. The product requires only 5 µl of whole blood, delivers results in approximately two minutes, has a 24-month shelf life at 5–37 °C without refrigeration, and is validated to 99.9% concordance with standard laboratory methods across multi-country studies. The EldonCard is ISO 13485 certified, CE marked in the EU, cleared by the US FDA, and listed on the WHO Essential Diagnostics List and the WHO Compendium of Innovative Health Technologies for Low-Resource Settings.

The company's product portfolio centers on the core EldonCard and includes a dedicated Rhesus card for maternal health settings, a single-use safety lancet, and a home blood type testing kit sold through Amazon. Eldon Biologicals earns revenue primarily through one-time sales of cards and accessories to healthcare providers, hospitals, military medical units, NGOs, and clinical laboratories, channeled through a global authorized distributor network spanning more than 40 countries across Europe, Africa, Asia, North America, South America, and Oceania; consumer home kits are sold directly through the Amazon marketplace. Commercial pricing is not publicly disclosed and is negotiated through distributors.

Eldon Biologicals maintains a small operational footprint (reported headcount of 1–10) and pursues impact-oriented partnerships with institutions including UNICEF, the Leiden University Medical Centre, Sanquin, the Kenya Obstetrical and Gynecological Society, the AFRICARhE Consortium, WIRhE, and tactical-medicine programs in Ukraine, focused on Rhesus disease prevention, postpartum hemorrhage management, and field blood typing.

ELDON firmographics

Firmographics
Name
ELDON
Legal name
Eldon Biologicals A/S
Website
https://eldoncard.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Eldon Biologicals A/S is a Danish medical device manufacturer that produces the EldonCard, a dry-format point-of-care blood typing card for ABO and Rhesus D determination, serving hospitals, militaries, NGOs, and consumers via a global distributor network and Amazon.
Ownership category
akta.pro rank

ELDON industry classification

Industry
Product category
In-Vitro Diagnostic Medical Devices
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAH
Blood Bank, Transfusion Medicine & Immunohematology
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAG
Transfusion Medicine & Immunohematology (Blood Bank)

Keywords

  • Blood grouping cards
  • Point-of-care diagnostics
  • ABO Rhesus typing
  • Dry format immunohematology
  • Home blood type testing

Where ELDON is headquartered

Location

Headquarters

HQ city
Gentofte
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

ELDON business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Medical Device Sales: Sale of EldonCards and related blood typing products to healthcare providers, hospitals, military medical units, and clinical laboratories globally through distributor network.
  2. Consumer/Home Testing Kits: Direct-to-consumer sales of home blood type testing kits through Amazon marketplace for individual users wanting to know their blood type.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels3 records

ELDON product offering

Product offering

Core offering

Eldon Biologicals A/S manufactures and sells the EldonCard product line, a dry-format point-of-care blood typing system for ABO and Rhesus D blood grouping. The cards use dried monoclonal antibody formulations on special plastic substrates and deliver blood type results in approximately 2 minutes from as little as 5 µl of whole blood, without refrigeration or laboratory infrastructure. The portfolio serves healthcare providers, military medical units, maternal health programs, NGOs, and individual consumers through a global distributor network and Amazon home-test kits.

Product overview

Eldon Biologicals A/S manufactures and sells the EldonCard product line—a dry format blood typing system for ABO and Rhesus (D) blood grouping. The core EldonCard product consists of plastic cards with dried monoclonal antibody formulations that provide rapid, point-of-care blood type determination without requiring refrigeration or laboratory equipment. The portfolio includes the standard EldonCard, the Home Kit for personal blood type testing, the specialized Rhesus Card for maternal health settings, and single-use safety lancets. The system is designed for both professional medical use and home testing, delivering results in 2 minutes from minimal blood samples.

Differentiator

Problem solved

Functional benefit

Products and services

  • EldonCard Dry-format plastic card with dried monoclonal antibody reagents used for point-of-care ABO and Rhesus D blood grouping. Provides blood type results in 2 minutes from 5 µl of whole blood without refrigeration or laboratory equipment; shelf life 24 months at 5–37 °C; ISO 13485, CE marked, US FDA cleared.
  • Eldon Blood Type Test (Home Kit) Consumer home blood typing kit containing an EldonCard with four circles of dried antibody reagents plus an instructions guide for interpreting agglutination patterns. Sold directly to individual consumers via Amazon for personal blood type determination.
  • Eldon Safety Lancet Disposable single-use safety lancet with a post-use activation safety mechanism that prevents accidental piercing, used to draw the small whole-blood sample required for the EldonCard test.
  • EldonCard Rhesus Card Specialized EldonCard variant designed for Rhesus status screening of pregnant women in birth centres, birth clinics, and abortion clinics to support Rhesus disease prophylaxis and maternal health programs.

Quantifiable outcome

  • 99.9% concordance with standard blood typing procedures in multi-country laboratory validation studies
  • +3 more outcomes

Companies that use ELDON

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

ELDON technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ELDON partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • PULSE - Tactical Medicine for UkrainecoreStrategic or Co-development Partner · 19 March 2025Partnership for pre-hospital blood transfusion training for Ukrainian Armed Forces. EldonCards used for rapid blood type determination in combat medicine scenarios, enabling timely life-saving transfusions.
  • UNICEFcoreStrategic or Co-development Partner · 30 September 2024Partnership to provide UNICEF with EldonCards as a tool strengthening maternal and child health programs across UNICEF's operations in over 190 countries.
  • DonorUAcoreStrategic or Co-development Partner · 10 October 2023Ukrainian blood donor organization partnership for Walking Blood Bank initiative. Donor registration and free blood type testing using EldonCards at outreach activities.
  • AFRICARhE ConsortiumcoreStrategic or Co-development Partner · 1 September 2023Three-country initiative in Ethiopia, Malawi, and Tanzania involving LUMC, Sanquin, Haramaya University, Hiwot Fana Specialized University Hospital, Queen Elizabeth Central Hospital, and Kilimanjaro Christian Medical Centre. Blood type testing of 10,000 pregnant women per country.
  • Caritas AfricaminorStrategic or Co-development Partner · 1 May 2023Presentation of EldonCard at Caritas Africa General Assembly in Rome. Discussions on Rhesus disease prevention and blood donor mobilization across African healthcare systems.
  • Kenya Obstetrical and Gynecological Society (KOGS)coreStrategic or Co-development PartnerEU-funded pilot project implementing Rhesus disease prevention through blood type testing of pregnant women using EldonCards. Part of the broader End PPH Project targeting postpartum hemorrhage.
  • Walking Blood Bank UkrainecoreStrategic or Co-development PartnerPartnership with DonorUA and Yashchenko Foundation to develop and expand Walking Blood Bank in Ukraine, addressing shortage of donor blood through rapid blood type testing and donor registration.
  • End PPH ProjectcoreStrategic or Co-development PartnerPartnership including KOGS, Midwifes Association of Kenya, University of Nairobi to tackle postpartum hemorrhage - a leading cause of maternal mortality in Kenya (25-45% of maternal deaths). EldonCards support blood donor mobilization.
  • SanquincoreStrategic or Co-development PartnerDutch blood services provider collaborating on African Rhesus disease prevention projects. Discussed cooperation focusing on field testing and scaling up Rhesus disease prevention in Ethiopia, Malawi, and Tanzania.
  • Leiden University Medical Centre (LUMC)coreStrategic or Co-development PartnerLeading global initiative to eradicate Hemolytic Disease of the Fetus and Newborn (HDFN/Rhesus disease). Developed two-phase study to tackle the disease in sub-Saharan Africa.
  • WIRhE (Worldwide Initiative for Rh Disease Eradication)coreStrategic or Co-development PartnerGlobal partnership dedicated to Rhesus disease eradication. Eldon Biologicals supports efforts with point-of-care testing technology for screening and prevention programs.
  • Protected Workplaces for Disabled EmploymentminorOthersCooperation with seven different protected workplaces providing genuine employment opportunities for people living with disabilities in production and assembly.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

ELDON competitors and assessment

Company assessment

Broad incumbents

  • Bio-Rad Laboratories: Bio-Rad's DiaMed line supplies blood typing reagents, gel cards, and instrumentation used in transfusion medicine. As a broad diagnostics incumbent, Bio-Rad overlaps with Eldon in the same clinical workflow but offers a much wider product portfolio.
  • Siemens Healthineers: Siemens Healthineers offers blood typing and immunohematology solutions as part of its central lab diagnostics franchise. It targets the same clinical use case as EldonCard but via high-throughput analyzers in established lab environments.
  • Grifols Diagnostic Solutions: Grifols produces blood typing reagents and is a major player in transfusion diagnostics as part of its broader plasma and diagnostics business. It competes with Eldon in the same clinical indication but with a portfolio-focused, integrated blood bank offering.
  • Abbott Diagnostics: Abbott is a global diagnostics incumbent offering blood typing and transfusion-related assays as part of its broader core lab and POC portfolio. It competes with Eldon for hospital transfusion medicine budgets, though ABO/Rhesus is a small slice of its portfolio.
  • Ortho Clinical Diagnostics (QuidelOrtho): QuidelOrtho manufactures immunohematology reagents and the ORTHO VISION analyzer for blood banks. It addresses the same clinical need as EldonCard (ABO/Rhesus determination) but is geared toward centralized hospital labs rather than field point-of-care use.

Direct peers

  • Immucor (Werfen): Immucor, now part of Werfen, is a global leader in transfusion and immunohematology diagnostics, offering manual and automated blood typing reagents and instruments. It is the most direct large-scale competitor to EldonCard in hospital blood bank workflows.
  • Quotient Limited: Quotient develops the MosaiQ blood transfusion diagnostics platform for donor typing and patient screening. It competes with EldonCard at the immunohematology testing step in blood banks, though via a higher-throughput centralized instrument rather than a point-of-care card.
  • Silver Lake Research (Typenex): Silver Lake Research markets the Typenex home blood typing kit, a direct analogue of Eldon's Amazon home kit. It is the closest pure-play comparable in the consumer blood typing segment where Eldon also competes.

Emerging players

  • HemoCue (Radiometer/Danaher): HemoCue provides point-of-care blood diagnostics (notably hemoglobin and glucose) for field and primary care settings. While not a direct blood typing competitor, it is comparable as a small-format, no-refrigeration POC diagnostics brand addressing similar low-resource and emerging-market customers.
  • Biomedomics: Biomedomics develops point-of-care blood typing tests targeted at low-resource settings, including a lateral flow typing device. It is the closest emerging direct competitor to EldonCard in field/decentralized blood typing use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

ELDON social profiles

Digital presence

ELDON compliance and trust

Trust signal

Compliance3 records

ELDON financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ELDON leadership team

Management profile

Number of profiles

Profiles4 records

ELDON funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ELDON M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELDON

What does ELDON do?

Eldon Biologicals A/S manufactures and sells the EldonCard product line, a dry-format point-of-care blood typing system for ABO and Rhesus D blood grouping. The cards use dried monoclonal antibody formulations on special plastic substrates and deliver blood type results in approximately 2 minutes from as little as 5 µl of whole blood, without refrigeration or laboratory infrastructure. The portfolio serves healthcare providers, military medical units, maternal health programs, NGOs, and individual consumers through a global distributor network and Amazon home-test kits.

Is ELDON a public or private company?

ELDON is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ELDON founded?

ELDON was founded in -1. It employs 11 to 50 people.

Where is ELDON based?

ELDON is headquartered in Gentofte, Denmark, in the Europe region.

How does ELDON make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are consumer/Home Testing Kits.

Who are ELDON's main competitors?

Broad incumbents on record are Bio-Rad Laboratories, Siemens Healthineers, Grifols Diagnostic Solutions, Abbott Diagnostics and Ortho Clinical Diagnostics (QuidelOrtho). Direct peers are Immucor (Werfen), Quotient Limited and Silver Lake Research (Typenex). Emerging players are HemoCue (Radiometer/Danaher) and Biomedomics.

Does ELDON have an API?

No public API is recorded for ELDON.

What industry is ELDON in?

ELDON's product category is In-Vitro Diagnostic Medical Devices. Its primary akta.pro industry code is HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology, with a secondary code of HLAFAMAG, Transfusion Medicine & Immunohematology (Blood Bank). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals